China Biologic cleans up in Chinese blood market and looks for partnerships in rDNA
This article was originally published in Scrip
Executive Summary
The Chinese blood products company, China Biologic Products, is looking to secure its supplies of plasma and to extend its market reach to all provinces in China, a market on which its current business is now heavily reliant.